Clinical Research Directory

Inclusion Criteria: * Ability to understand and the willingness to sign a written informed consent document. * Age ≥ 18 years and ≤ 80 years. * Eastern Cooperative Oncology Group (ECOG) performance status 0-2. * Histologically or cytologically confirmed metastatic pancreas adenocarcinoma. * History of diabetes mellitus, or newly diagnosed diabetes meeting the diagnostic criteria of the American Diabetes Association. * The expected survival ≥ 3 months. * Able to comply with study visit schedules and other protocol requirements. Exclusion Criteria: * • History of other malignancies requiring anti-cancer therapy within 2 years prior to enrollment (except treated Stage I prostate cancer, in situ cervical cancer, in situ breast cancer, etc.); * Non-primary pancreatic cancer patients; * Digestive tract inflammation, including biliary tract infection, gastrointestinal infection, pancreatitis, etc.; * Pregnant or lactating women.